RxDoctor Payments Data

Lisa York, MD

Family Medicine · Victoria, VANPI 1295730778

Payments from drug & device makers

$179in general payments, 2019–2025

Across 8 payments — averaging $22.39 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$41
  • AbbVie$37
  • Vanda Pharmaceuticals Inc.$33
  • Mylan Specialty L.p.$33
  • Inspire Medical Systems, Inc.$22
  • Novo Nordisk$13

What the payments were for

  • Food & beverage$179100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
23

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$179 in reported general payments places this provider in the 40th percentile of 2,553 family medicine providers in Virginia.

See all family medicine providers in Virginia

Medicare billing

Part B allowed, 2024
$127,498
Medicare patients
238
Services billed
1,947

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
JardianceEmpagliflozin114$111,607
EliquisApixaban127$106,661
OzempicSemaglutide85$91,506
RybelsusSemaglutide45$72,557
Trelegy ElliptaFluticasone/Umeclidin/Vilanter61$49,315
JanuviaSitagliptin Phosphate59$48,342
TrulicityDulaglutide20$38,957
FarxigaDapagliflozin Propanediol30$25,666
XareltoRivaroxaban37$23,455
LinzessLinaclotide18$20,253
Lantus SolostarInsulin Glargine,hum.Rec.Anlog87$11,296
Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog25$8,360
Fluticasone-SalmeterolFluticasone Propion/Salmeterol38$6,735
Varenicline Tartrate26$6,642
Albuterol Sulfate HfaAlbuterol Sulfate174$5,688

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic, Rybelsus$13$164,063130 claims
AstraZenecaFarxiga$41$25,66630 claims
AbbVieLinzess$37$20,25318 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 40th percentile of 2,553 family medicine providers in Virginia.

Other family medicine in Victoria

See the full list for Virginia

Where these figures come from

Is this you, or does something look wrong? →